Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EFCAB14 antisense RNA 1 (EFCAB14-AS1) is a long non-coding RNA (lncRNA) gene transcribed from the opposite strand of the EFCAB14 gene locus, typically with regulatory functions at the RNA level[4][5][6]. It is not known to code for a protein, but rather is implicated in the regulation of gene expression, particularly by acting as an antisense transcript to the EFCAB14 protein-coding gene[4][5]. The lncRNA is described in genomic resources and databases but has no well-validated role as a therapeutic target or clear involvement in disease as of current knowledge[5][6][9]. There are no established drugs or biomarkers linked to this RNA, and its medical relevance, if any, has not yet been defined in the literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EFCAB14 antisense RNA 1 (EFCAB14-AS1).